Anesiva Commences Phase 2 Trial Of Adlea(TM) In Arthroscopic Shoulder Surgery

New cases in Pous 2064, HIV = 175, AIDS = 26, Death = 2. HIV rate is very high in Housewives than sex workers in Nepal ! ! ! HIV status in Nepal till 2005: Total Adult=70000, Adult Prevalence (15-49)=0.55%, Number of Women (15-49) LWHA=15,310 (22%), HIV Prevalence rate in IDUs=32.7%, HIV prevalence rate in sex worker=3.8%, HIV prevalence rate in client of SW=2.1%. The latest U.N. report shows that 65 million people have been infected with HIV since it was first identified 25 years ago. Twenty five million people have died of AIDS.

Welcome to the xenoMED, an online Medical Community where Academically sound, Professionally conscious and Socially responsible Medical Students, Doctors & Health Professionals interact with each other globally.

Medicine is the only profession that incessantly tries to destroy its own existence. Howsoever you may be associated with basic and/or clinical medicine - student or professor, physician or surgeon, undergraduate or postgraduate - this is your place to share your knowledge, and learn more. Just get the message across!

You are currently viewing our communiy as a guest which gives you limited access to view most discussions and access our other features. By joining our free community you will have access to post topics, communicate privately with other members (PM), respond to polls, upload content and access many other special features. Registration is fast, simple and absolutely free so please, Join Our Medical Cummunity Today!

If you have any problems with the registration process or your account login, please contact us.

		xenoMED > News Room > Health News > Medical News Today
Anesiva Commences Phase 2 Trial Of Adlea(TM) In Arthroscopic Shoulder Surgery

(#1 (permalink))

News is Offline

Senior Member

Posts: 677

Thanks: 0

Thanked 35 Times in 35 Posts

Join Date: Sep 2007

Anesiva Commences Phase 2 Trial Of Adlea(TM) In Arthroscopic Shoulder Surgery - 18-07-2008, 03:20 AM

Anesiva, Inc. (Nasdaq: ANSV) announced that it has begun a Phase 2 clinical trial of Adlea(TM), the company's long-acting, site specific, non-opioid drug candidate for the management of acute pain in patients undergoing arthroscopic shoulder surgery involving rotator cuff repair. Adlea is currently in two pivotal Phase 3 trials in the U.S.

More...

« Salmonella Update: FDA Says All Tomatoes Now Safe To Eat | Report On Climate Change And Health Released By EPA »

Thread Tools	Search this Thread
Show Printable Version Email this Page	Search this Thread: Advanced Search
Display Modes
Linear Mode Switch to Hybrid Mode Switch to Threaded Mode

Posting Rules
You may not post new threads You may not post replies You may not post attachments You may not edit your posts BB code is On Smilies are On [IMG] code is On HTML code is Off Trackbacks are On Pingbacks are On Refbacks are On

Similar Threads
Thread	Thread Starter	Forum	Replies	Last Post
Cosmetic and Plastic Surgery	neogenic	Ask Doctor	2	01-03-2008 12:52 AM
Anesiva Completes Enrollment In Phase 3 Clinical Trial Of Zingo(TM) To Treat Pain Ass	Angel	Medical News Today	0	29-08-2007 01:40 AM
Pharmos Commences Phase 2a Trial Of Topical Diclofenac NanoEmulsion Cream	Angel	Medical News Today	0	28-06-2007 12:30 AM
Anesiva Announces Clinical Data From Phase 1 Trial Of 1207	Angel	Medical News Today	0	19-01-2007 12:13 AM

Hosted and Maintained by: